New MS drug set for phase 2 testing
Experimental MS therapy Lucid-MS is moving towards phase 2 testing [...]
Experimental MS therapy Lucid-MS is moving towards phase 2 testing [...]
A Liverpool neuroscience centre has gained WHO Collaborating Centre status [...]
Traumatic brain injury (TBI) can have lasting effects on the [...]
Adult social care provider National Care Group has promoted Wendy [...]
A brief, personalised rehabilitation programme may help people with MS [...]
There is still time for charities supporting people affected by [...]
A new pill could offer hope to people with Parkinson’s [...]
The National MS Society raised more than US$12m on the [...]
Belfast has opened what is described as the UK's first [...]
Tom’s Trust co-founder Deborah Mitchell is stepping away from the [...]